Oak Thistle LLC Invests $2.02 Million in Humana Inc. (NYSE:HUM)

Oak Thistle LLC acquired a new stake in Humana Inc. (NYSE:HUM - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 7,614 shares of the insurance provider's stock, valued at approximately $2,015,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. MCF Advisors LLC grew its stake in shares of Humana by 3.4% during the 1st quarter. MCF Advisors LLC now owns 3,258 shares of the insurance provider's stock worth $864,000 after purchasing an additional 108 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH lifted its position in shares of Humana by 6.3% during the 1st quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 64,488 shares of the insurance provider's stock valued at $17,064,000 after buying an additional 3,799 shares in the last quarter. Guidance Capital Inc. purchased a new position in shares of Humana during the 1st quarter valued at approximately $245,000. HighPoint Advisor Group LLC lifted its position in shares of Humana by 15.2% during the 1st quarter. HighPoint Advisor Group LLC now owns 1,739 shares of the insurance provider's stock valued at $451,000 after buying an additional 230 shares in the last quarter. Finally, Gries Financial LLC purchased a new position in shares of Humana during the 1st quarter valued at approximately $221,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. Mizuho increased their target price on Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Guggenheim initiated coverage on shares of Humana in a research note on Wednesday, April 9th. They set a "buy" rating and a $326.00 target price on the stock. Bank of America lowered their target price on shares of Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a research note on Tuesday, June 17th. Robert W. Baird cut their price objective on shares of Humana from $300.00 to $297.00 and set a "neutral" rating for the company in a research report on Friday. Finally, Raymond James Financial raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 target price on the stock in a research note on Thursday, May 1st. Sixteen equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $282.43.

Humana Trading Up 3.9%

NYSE HUM traded up $9.01 during trading on Friday, hitting $238.22. The stock had a trading volume of 1,569,145 shares, compared to its average volume of 1,505,668. The company has a market capitalization of $28.75 billion, a PE ratio of 16.85, a PEG ratio of 1.57 and a beta of 0.44. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.71. The firm has a 50 day moving average price of $234.56 and a 200 day moving average price of $256.27. Humana Inc. has a twelve month low of $206.87 and a twelve month high of $406.09.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, beating the consensus estimate of $10.07 by $1.51. The company had revenue of $32.11 billion during the quarter, compared to the consensus estimate of $32 billion. Humana had a return on equity of 14.47% and a net margin of 1.42%. Humana's revenue was up 8.4% compared to the same quarter last year. During the same period in the previous year, the company posted $7.23 EPS. As a group, equities research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.